| Line item | 2025-11-30 FY | 2024-11-30 FY | 2023-11-30 FY | 2022-11-30 FY | 2021-11-30 FY |
|---|---|---|---|---|---|
| Revenue | $26.62B | $25.02B | $21.59B | $12.17B | $1.91B |
| Cost of Revenue | – | $15.64B | $14.32B | $11.76B | $4.66B |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $3.40B | $3.25B | $2.95B | $2.52B | $1.89B |
| Operating Income | $4.48B | $3.57B | $1.96B | -$4.38B | -$7.09B |
| Interest Expense | – | – | $2.07B | $1.61B | $1.60B |
| Tax Expense | $12.00M | -$1.00M | $13.00M | $14.00M | -$21.00M |
| Net Income | $2.76B | $1.92B | -$74.00M | -$6.09B | -$9.50B |
| EPS (basic) | 2.1000 | 1.5000 | -0.0600 | -5.1600 | -8.4600 |
| EPS (diluted) | 2.0200 | 1.4400 | -0.0600 | -5.1600 | -8.4600 |
| Shares (diluted) | $1.40B | $1.40B | $1.26B | $1.18B | $1.12B |